Anti-Thymoglobulin, Rabbit

Langerhans Cell Histiocytosis

M.D. Anderson Cancer CenterPhase 2Dormant

B

56/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 41/ 100
Competitive Position: 95/ 100

Competitive context

23 Active assets in the Langerhans Cell Histiocytosis cohort.

Asset / Sponsor	Phase	Rating
Olaparib National Cancer Institute (NCI)	Phase 2	B
Clofarabine M.D. Anderson Cancer Center	Phase 2	B
TACROLIMUS M.D. Anderson Cancer Center	Phase 2	B
Fludarabine M.D. Anderson Cancer Center	Phase 2	B
Evomela M.D. Anderson Cancer Center	Phase 2	B

View all 28 →

Same molecule, other indications

Anti-Thymoglobulin, Rabbit is also rated in:

myelodysplastic/myeloproliferative neoplasmDormant

BBB

Indicative ·

75 / 100

plasma cell myelomaDormant

BBB

Indicative ·

72 / 100

myeloproliferative neoplasmDormant

BB

Indicative ·

70 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.